When was Methuselah Medical Technology founded?

Methuselah Medical Technology was founded in 2012 and raised its 1st funding round 10 years after it was founded.

Where is Methuselah Medical Technology located?

Methuselah Medical Technology is headquartered in Shanghai, China.

Is Methuselah Medical Technology a funded company?

Methuselah Medical Technology is a funded company, having raised a total of $41.4M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 12, 2022.

When was the latest funding round of Methuselah Medical Technology?

Methuselah Medical Technology's latest funding was a $***** Series B round on Aug 04, 2025, with participation from 3 investors.

Where does Methuselah Medical Technology rank among its competitors?

Methuselah Medical Technology ranks 2nd amongst 6 active competitors, only 1 of which is funded. Methuselah Medical Technology, which secured $13.9M in Aug, 2025.

Who are the top competitors of Methuselah Medical Technology?

Methuselah Medical Technology's top competitors include Tasly, Sinopharm and Yixintang Pharmaceutical. Among them, Methuselah Medical Technology secured the most recent funding round in August, 2025.

Methuselah Medical Technology - 2026 Company Profile, Funding & Competitors

Methuselah Medical Technology is a series B company based in Shanghai (China), founded in 2012. It operates as a Supplier and manufacturer of medical nutrition products. Methuselah Medical Technology has raised $41.4M in funding from investors like CICC, Hudson Capital and 上海市商业投资（集团）有限公司. The company has 6 active competitors, including 1 funded and 2 that have exited. Its top competitors include companies like Tasly, Sinopharm and Yixintang Pharmaceutical.

Company Details

Website: mn969.com
Email ID: *****@163.com
Phone Number: +86 **********

Key Metrics

Founded Year

2012

Location

Shanghai, China

Stage

Series B

Total Funding

$41.4M in 3 rounds

Latest Funding Round

Series B, Aug 04, 2025, $*****

Investors

CICC & 6 more

Ranked

2^nd among 6 active competitors

Similar Companies

Tasly & 74 more

View Methuselah Medical Technology's full profile

Methuselah Medical Technology has raised a total funding of $41.4M over 3 rounds. Its first funding round was on Dec 12, 2022. Its latest funding round was a Series B round on Aug 04, 2025 for $*****. 3 investors participated in its latest round. Methuselah Medical Technology has 7 institutional investors.

Here is the list of recent funding rounds of Methuselah Medical Technology:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 04, 2025	4561499	Series B	4788800	6310575	4534674	5566159
Feb 19, 2025	5538914	Series B	6977566	3485336	8079960	Borchid Capital & 1 more
Dec 12, 2022	7490492	Series A	7456507	7764561	8646498	Frees Fund

Access funding benchmarks and valuations. Sign up today!

View details of Methuselah Medical Technology's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Methuselah Medical Technology include Tasly, Sinopharm and Yixintang Pharmaceutical. Here is the list of Top 10 competitors of Methuselah Medical Technology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tasly 1994, Tianjin (China), Public	Manufacture and distributor of traditional Chinese medicine	-	BOCOM International, Ally Bridge Group	61/100
2nd	Methuselah Medical Technology 2012, Shanghai (China), Series B	Supplier and manufacturer of medical nutrition products	$41.4M	CICC, HLC & 5 others	45/100
3rd	Sinopharm 2003, Shanghai (China), Public	Manufacturer and distributor of chinese medicines	-	-	34/100
4th	Yixintang Pharmaceutical 2000, Kunming (China), Funding Raised	Distributor and retailer of chinese pharmaceutical products	-	Spinnotec, Legend Capital	28/100
5th	Ctqjpharm 1970, Huai an (China), Unfunded	Manufacturer of active pharmaceutical ingredients, pharmaceutical intermediates, and chemical intermediates	-	-	18/100
6th	medicinal materials trading network 2015, Shanghai (China), Unfunded	Distributor of chinese herbal medicines	-	-	16/100
7th	BiggerMax 2015, Beijing (China), Deadpooled	Distributor of chinese medicines	-	Kaitai Capital Management	15/100